Morjana N, Tal R
Chemistry Research and Development, Dade Behring, P.O. Box 520672, Miami, FL 33152-0672, USA.
Biotechnol Appl Biochem. 1998 Aug;28(1):7-17.
Human cardiac troponin I has been expressed at high level in Escherichia coli as a fusion protein by using the expression vector Ptac114. The expressed protein forms primarily intracellular inclusion bodies that are solubilized in the presence of 8 M urea. The purified troponin I is recognized by anti-(human cardiac troponin I) monoclonal antibodies. Equilibrium denaturation of recombinant human troponin I and bovine troponin I is compared by monitoring changes in the protein's fluorescence and CD characteristics. At pH 7.5 the equilibrium denaturation of both proteins by urea occurs in two distinct steps involving at least three major conformational states: native, intermediate and fully denatured. The biphasic profile in the presence of urea is observed by both fluorescence and CD spectroscopy. In the intermediate state the native tertiary structure is largely disrupted and 40% of the secondary structure is conserved, as suggested by near-UV and far-UVCD respectively. Thermal denaturation of troponin I, as followed by fluorescence, shows a loss in the signal that is not reversible after heating to 90 degrees C. In the presence of a constant amount of urea (not greater than 0.5 M) the thermal denaturation becomes biphasic, suggesting the accumulation of an intermediate species that is stabilized by urea. The fluorescence of 1-anilino-8-naphthalenesulphonate produced on binding troponin I decreases in the presence of increasing concentrations of urea up to 3 M; at higher urea concentrations no further change in the remaining signal is observed. Kinetic studies show at least two phases of renaturation for troponin I previously denatured with 8 M urea, whereas only a single phase is detected for the renaturation process in the presence of 3 M urea. The results suggest the occurrence of a stable folding intermediate, the formation of which might be related to the two-domain architecture of troponin I.
利用表达载体Ptac114,人心脏肌钙蛋白I在大肠杆菌中作为融合蛋白高水平表达。表达的蛋白主要形成细胞内包涵体,在8M尿素存在下可溶解。纯化的肌钙蛋白I可被抗(人心脏肌钙蛋白I)单克隆抗体识别。通过监测蛋白质荧光和圆二色性特征的变化,比较重组人肌钙蛋白I和牛肌钙蛋白I的平衡变性。在pH 7.5时,尿素对两种蛋白质的平衡变性分两个不同步骤进行,涉及至少三种主要构象状态:天然态、中间态和完全变性态。通过荧光和圆二色光谱都观察到了尿素存在下的双相图谱。在中间态,天然三级结构大部分被破坏,分别由近紫外和远紫外圆二色性表明40%的二级结构得以保留。肌钙蛋白I的热变性通过荧光监测,加热至90℃后信号丧失且不可逆。在恒定浓度的尿素(不大于0.5M)存在下,热变性变为双相,表明积累了一种被尿素稳定的中间物种。随着尿素浓度增加至3M,与肌钙蛋白I结合产生的1-苯胺基-8-萘磺酸盐荧光降低;在更高尿素浓度下,未观察到剩余信号有进一步变化。动力学研究表明,先前用8M尿素变性的肌钙蛋白I复性至少有两个阶段,而在3M尿素存在下复性过程仅检测到一个阶段。结果表明存在一种稳定的折叠中间体,其形成可能与肌钙蛋白I的双结构域结构有关。